XML 23 R78.htm IDEA: XBRL DOCUMENT v2.4.0.8
Financial Instruments and Fair Value Measurements (Narrative) (Details) (USD $)
In Millions, unless otherwise specified
3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended
Mar. 28, 2014
Mar. 29, 2013
Mar. 28, 2014
Mar. 29, 2013
Mar. 28, 2014
Spain and Italy
Mar. 29, 2013
Spain and Italy
Mar. 28, 2014
Spain and Italy
Mar. 29, 2013
Spain and Italy
Mar. 28, 2014
CNS Therapeutics, Inc.
Oct. 01, 2012
CNS Therapeutics, Inc.
Mar. 28, 2014
Debentures
8.00% Debenture
Level 2
Mar. 28, 2014
Debentures
9.50% Debenture
Level 2
Apr. 30, 2013
Senior Notes
3.50% Senior Note
Mar. 28, 2014
Senior Notes
3.50% Senior Note
Level 1
Apr. 30, 2013
Senior Notes
4.75% Senior Note
Mar. 28, 2014
Senior Notes
4.75% Senior Note
Level 1
Mar. 28, 2014
Other Assets
Carrying Value
Level 1
Sep. 27, 2013
Other Assets
Carrying Value
Level 1
Mar. 28, 2014
Other Assets
Carrying Value
Level 3
Sep. 27, 2013
Other Assets
Carrying Value
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]                                        
Fair value of contingent consideration upon acquisition                   $ 6.9                    
Maximum contingent payments for acquisition                   9.0                    
Discount rate                 1.00%                      
Restricted cash                                 20.2 24.0    
Cash surrender value of life insurance                                     68.7 67.7
Stated interest rate                     8.00% 9.50% 3.50% 3.50% 4.75% 4.75%        
Net sales $ 557.8 $ 585.3 $ 1,098.0 $ 1,089.3 $ 12.4 $ 14.1 $ 24.7 $ 26.3